1. Home
  2. VRTX vs ADP Comparison

VRTX vs ADP Comparison

Compare VRTX & ADP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRTX
  • ADP
  • Stock Information
  • Founded
  • VRTX 1989
  • ADP 1949
  • Country
  • VRTX United States
  • ADP United States
  • Employees
  • VRTX N/A
  • ADP N/A
  • Industry
  • VRTX EDP Services
  • ADP EDP Services
  • Sector
  • VRTX Technology
  • ADP Technology
  • Exchange
  • VRTX Nasdaq
  • ADP Nasdaq
  • Market Cap
  • VRTX 115.6B
  • ADP 119.7B
  • IPO Year
  • VRTX 1991
  • ADP N/A
  • Fundamental
  • Price
  • VRTX $470.43
  • ADP $302.65
  • Analyst Decision
  • VRTX Buy
  • ADP Hold
  • Analyst Count
  • VRTX 25
  • ADP 13
  • Target Price
  • VRTX $508.91
  • ADP $310.62
  • AVG Volume (30 Days)
  • VRTX 1.3M
  • ADP 1.8M
  • Earning Date
  • VRTX 08-04-2025
  • ADP 07-30-2025
  • Dividend Yield
  • VRTX N/A
  • ADP 2.04%
  • EPS Growth
  • VRTX N/A
  • ADP 9.27
  • EPS
  • VRTX N/A
  • ADP 9.78
  • Revenue
  • VRTX $11,099,700,000.00
  • ADP $20,202,600,000.00
  • Revenue This Year
  • VRTX $10.48
  • ADP $7.74
  • Revenue Next Year
  • VRTX $10.69
  • ADP $5.68
  • P/E Ratio
  • VRTX N/A
  • ADP $30.94
  • Revenue Growth
  • VRTX 8.98
  • ADP 6.83
  • 52 Week Low
  • VRTX $377.85
  • ADP $233.14
  • 52 Week High
  • VRTX $519.88
  • ADP $329.93
  • Technical
  • Relative Strength Index (RSI)
  • VRTX 60.14
  • ADP 41.18
  • Support Level
  • VRTX $455.79
  • ADP $305.26
  • Resistance Level
  • VRTX $484.56
  • ADP $310.81
  • Average True Range (ATR)
  • VRTX 8.51
  • ADP 5.47
  • MACD
  • VRTX 3.43
  • ADP -0.13
  • Stochastic Oscillator
  • VRTX 68.83
  • ADP 38.71

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

About ADP Automatic Data Processing Inc.

Automatic Data Processing is a global technology company providing cloud-based human capital management solutions enabling clients to better implement payroll, talent, time, tax, and benefits administration. Additionally, ADP provides human resource outsourcing solutions that allow customers to offload some of their traditional HR tasks. The company operates through two segments: employer services and the professional employer organization services. Employer services consists of the company's HCM products as well as a la carte HRO solutions. PEO services contains ADP's comprehensive HRO solution where it acts as a co-employer with its customer. As of fiscal 2024, ADP serves over 1.1 million clients and pays over 42 million workers across 140 countries.

Share on Social Networks: